FDA Lacks Methodology To Determine Budgetary Needs, GAO Report Finds
This article was originally published in The Gray Sheet
Executive Summary
According to a Government Accountability Office report released July 20, FDA not only lacks resources, but the agency has no credible method for determining the exact funding it needs
You may also be interested in...
GAO “High-Risk List” Urges Enhanced FDA Oversight Of Medical Products
The Government Accountability Office added enhanced oversight of devices, drugs and other medical products to its list of "high-risk" priorities in a report to Congress released Jan. 22
FDA Inspections Of Foreign Device Manufacturers Anemic – GAO Testimony
FDA's effectiveness in conducting device manufacturing inspections overseas was criticized by the Government Accountability Office in testimony before Congress that found overall "weaknesses" in the agency's inspection of medical device manufacturers
FDA Bill Signed Into Law; CDRH Set To Implement Fee-Based e-Registration
President Bush Sept. 27 signed into law the FDA Amendments Act, setting in motion significant reforms in the way the agency will oversee the safety of health care products